Although an expensive and challenging regulatory market, Japan’s aging population offers plenty of opportunities for device companies.
It’s critical to understand the characteristics of this country’s market to determine the most effective steps.
With the exception of a few countries, Asia’s disease management industry is relatively unstructured.
While Western countries still have more medical device startups than the rest of the world, more new medtech startups are popping up in Asia than ever before.
As standalone software becomes increasingly sophisticated, a number of regulatory bodies have begun to draft separate guidelines to ensure quality control, expedite product approval, and improve patient access to new technologies.
Global sports medicine is predicted to grow to around $35 billion by 2022, with the Asian market growing at a compound annual growth rate of nearly 7 percent.
As Asians get wealthier and more concerned about how they look, opportunities in Asia’s aesthetic market will skyrocket.
Growth of the Asian cloud computing market is expected to accelerate as healthcare providers streamline their operations in today’s paperless world.
As the continent becomes a bigger player, western companies should explore the potential prospects.
With the largest patient population in the world, the region has high growth potential over the next few years.